GGrantIndex
Sort

15,440 grants matching organoids

Role of hypoxia in CD8+ T cell exclusion and suppression in pancreatic cancer

$42,228
Ashley Mello · University Of Michigan At Ann Arbor · F31 · FY2025 · CA

Deciphering Mechanisms of Limb Malformations Caused by Noncoding Variants In Vivo

$42,223
Ethan W Hollingsworth · University Of California-Irvine · F30 · FY2022 · HD

Strategies in Renal Nanomedicine to Impact Treatment Paradigms in Kidney Disease

$42,212
Bilal Abdullah Naved · Northwestern University At Chicago · F30 · FY2021 · DK

Elucidating the Role of Notch/HES Signaling in Alveolar Epithelial Type II to Type I Cell Differentiation

$42,094
Jessica Liang · University Of Michigan At Ann Arbor · F31 · FY2024 · HL

Inter-organellar communication in metabolic reprogramming of colorectal cancer

$42,094
Brandon Chen · University Of Michigan At Ann Arbor · F99 · FY2024 · CA

Bile Acids

$42,079
Kevin Michael Tveter · Rutgers, The State Univ Of N.J. · F31 · FY2021 · AT

Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress

$42,070
Adriana Baker · University Of Texas Hlth Science Center · F30 · FY2025 · CA

Developing an Ex Vivo Model of the Mesolimbic Pathway for Studying Addiction Phenotypes

$42,042
Thomas Rudibaugh · North Carolina State University Raleigh · F31 · FY2022 · DA

Predoctoral to Postdoctoral Research Training in ctDNA Biology for Liquid Biopsy of Cancer

$42,028
Jordan C Cheng · University Of California Los Angeles · F99 · FY2021 · CA

Functions of KAT2A and KAT2B in intestinal homeostasis and colon cancer.

$42,026
Mai Uyen Nguyen · Rutgers, The State Univ Of N.J. · F31 · FY2021 · CA

Characterization of Cardiac Behavior as a Function of Topology

$42,018
Stephen Ma · Columbia University Health Sciences · F30 · FY2016 · HL

A patient-specific hiPSC model of breast cancer to identify genetic determinants of subclonal response and resistance to PARP inhibitors

$41,965
Carly Jacquelyn Weddle · Northwestern University At Chicago · F31 · FY2022 · CA

Program 02: Gynecologic Cancers

$41,955
Ursula Anne Matulonis · Dana-Farber Cancer Inst · P30 · FY2022 · CA

Program 02: Gynecologic Cancers

$41,955
Ursula Anne Matulonis · Dana-Farber Cancer Inst · P30 · FY2023 · CA

Identifying developmental trajectories characterized in the neuroepithelial stem cell to radial glia transition using single-cell transcriptomics

$41,938
Ugomma Eze · University Of California, San Francisco · F31 · FY2021 · NS

Mechanistic studies of the NRF2-Methylosome interaction in lung cancer.

$41,904
Santiago Espinosa De Los Reyes · State University New York Stony Brook · F31 · FY2025 · CA

Brain microenviornment-dependent lineage plasticity drives adaptation to targeted therapy in malignant gliomas

$41,892
Dimitri Cadet · University Of California Los Angeles · F30 · FY2025 · CA

Mechanisms of BMP signaling driving tissue pattern in the intestine

$41,882
Alexandra Logerfo · Rutgers, The State Univ Of N.J. · F31 · FY2024 · DK

Elucidating the pathogenic mechanisms by which KAT6A mutations alter human in vitro neurodevelopment

$41,872
Aileen Anai Nava · University Of California Los Angeles · F31 · FY2025 · NS

Functional Genomic Interrogation of Autism Spectrum Disorder Genetic Risk on Microglia-Neuronal Interactions

$41,872
Natalie Hawken · University Of California Los Angeles · F30 · FY2025 · MH

Pathways of oncogene-induced senescence at DNA replication forks

$41,841
Jennifer Park · State University New York Stony Brook · F31 · FY2025 · CA

An Engineered Hydrogel Platform to Improve Neural Organoid Reproducibility for a Multi-Organoid Disease Model of 22q11.2 Deletion Syndrome

$41,787
Michelle S Huang · Stanford University · F31 · FY2024 · NS

Role of interleukin-6 signaling on T cell potential of aged hematopoietic stem cells and thymic progenitors

$41,771
Julia Gensheimer · University Of California Los Angeles · F30 · FY2025 · AG

Understanding OPA1 mutation-driven dominant optic atrophy using human PSC-derived retinal ganglion cells

$41,769
Katherine Anne Pohl · University Of California Los Angeles · F31 · FY2022 · EY

System analysis of p53 mutant associated cancer development with LFS patient- specific iPSCs

$41,724
Huensuk Kim · Icahn School Of Medicine At Mount Sinai · F99 · FY2017 · CA